Meta-analysis reveals iron supplementation improves hemoglobin in breastfed infants, suggesting tailored approaches for optimal health.
Aim: The aim for the study is to evaluate the effects of 1 mg/kg/day iron supplementation on hematologic and growth parameters in exclusively breastfed full‐term infants. Methods: We conducted a meta‐analysis of seven RCTs ( n = 1114) comparing iron supplementation with placebo/no intervention. Primary outcomes included hemoglobin (Hb), serum ferritin (SF), mean corpuscular volume (MCV), height, and weight. Data were analyzed using RevMan 5.4. Results: Iron supplementation from 4 to 6 months significantly increased Hb (MD = 6.29 g/L, p = 0.01), but effects diminished with longer duration (MD = 2.00 g/L, p = 0.08). For SF, no significant difference was found at 6 months, but supplementation significantly increased SF at 12 months (MD = 5.95 μ g/L, p = 0.04). No significant differences were found in MCV, height, or weight. Subgroup variations were noted by formulation and region. Conclusion: While short‐term iron supplementation improves iron status, the lack of sustained benefits suggests individualized approaches may be preferable to universal supplementation in well‐nourished populations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: